Absorbent article
By using metal oxide antibacterial agents blended with fibers in the front part of absorbent articles to form a multi-layered structure of the front part recess, the problem of the antibacterial agent being difficult to dissolve in water is solved, achieving a highly efficient antibacterial effect and low-cost antibacterial inhibition.
Patent Information
- Application Number
- CN202380026007.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-06-07
- Filing Date
- 2023-05-24
- Publication Date
- 2024-11-15
AI Technical Summary
In existing absorbent materials, antibacterial agents are difficult to dissolve effectively in water, which means that their antibacterial properties cannot be fully utilized before being penetrated by urine and other excretions, thus failing to effectively inhibit the occurrence of rashes.
In the front part of absorbent articles, metal oxide antibacterial agents are blended into fibers. By mixing metal oxide antibacterial agents into the fibers, a multi-layered structure of recessed front part is formed, ensuring that the antibacterial agent is in contact with excrement for a long time, reducing the dissolution and shedding of the antibacterial agent, and improving the antibacterial effect.
It achieves highly efficient antibacterial properties, inhibits rashes caused by excrement, reduces the adverse effects of metal oxide antibacterial agents on the skin, and lowers material costs.
Smart Images

Figure CN118973530A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to absorbent articles such as disposable diapers. Background Art
[0002] When wearing absorbent articles such as disposable diapers, sanitary napkins, panty liners (vaginal secretion pads), and incontinence pads, rashes may occur on the skin due to stuffiness, etc. Therefore, in order to suppress the occurrence of rashes, absorbent articles using antimicrobial agents in absorbent articles have been proposed.
[0003] For example, Patent Document 1 describes an absorbent article in which an antimicrobial agent is mixed into fibers constituting a front member that comes into contact with the wearer's skin.
[0004] In addition, Patent Document 2 describes an absorbent article, in which a front sheet having a concave-convex structure and an absorbent core or core wrapping sheet having a recessed portion contain an antibacterial agent, and the recessed portions (recessed portions) of the concave-convex structure of the front sheet and the recessed portions of the absorbent core are located at positions overlapping with an antibacterial agent configuration area where the antibacterial agent is configured when viewed from above.
[0005] Prior art literature
[0006] Patent Literature
[0007] Patent Document 1: Japanese Patent Application Publication No. 2006-55187
[0008] Patent Document 2: International Publication No. 2021 / 039513 Summary of the invention
[0009] An absorbent article according to one embodiment of the present invention has a longitudinal direction extending from the belly side of the wearer through the crotch portion to the back side, and a transverse direction orthogonal to the longitudinal direction, and is divided into a belly region, a crotch region, and a back region along the longitudinal direction.
[0010] The absorbent article has:
[0011] absorbent bodies arranged in the ventral region, the crotch region, and the dorsal region; and
[0012] A front piece is located on the skin side of the absorbent body.
[0013] The absorbent body has:
[0014] An absorbent core having a skin side and a non-skin side and having a slit portion penetrating in a thickness direction;
[0015] an upper backing paper covering the skin side including the slit portion; and
[0016] A lower backing paper covers the non-skin side including the slit portion.
[0017] The upper layer backing paper and the lower layer backing paper are joined at the slit portion.
[0018] The absorbent body has an absorbent body skin-side recessed portion formed by the slit portion on the skin-side surface thereof.
[0019] The front member has a front member recessed portion on the skin side thereof which is formed by the absorbent body skin side recessed portion.
[0020] The front member includes: a first region including a metal oxide antimicrobial agent; and a second region in which a mixing amount of the metal oxide antimicrobial agent is smaller than that of the first region.
[0021] The front element recess is formed by the first area.
[0022] The metal oxide antimicrobial agent is contained in the fiber. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 It is a perspective view showing an example of a disposable diaper (absorbent article) according to each embodiment of the present invention.
[0024] Figure 2 It is a plan view (top view) of the disposable diaper, showing a state viewed from the skin side (front member side) in a state where elastic members of various parts are stretched and developed in a planar shape.
[0025] Figure 3 (A) is a schematic cross-sectional view of a disposable diaper according to a first embodiment of the present invention, corresponding to Figure 2 The cross-sectional view taken along line IIIA-IIIA, (B) is Figure 3 (A) is an enlarged view of the vicinity of the recessed portion of the front piece surrounded by the dotted circle IIIB.
[0026] Figure 4 It is a schematic plan view showing the structure of the front material and the absorbent body (dashed line) of the disposable diaper according to the first embodiment.
[0027] Figure 5 It is a schematic cross-sectional view showing a part of the above-mentioned front member in an enlarged manner.
[0028] Figure 6 It is a schematic perspective view of the metal oxide antimicrobial agent mixed fiber used in the above-mentioned front member.
[0029] Figure 7 (A) is a schematic cross-sectional view of a disposable diaper according to a second embodiment of the present invention, corresponding to Figure 2 The cross-sectional view taken along line IIIA-IIIA, (B) is Figure 7(A) is an enlarged view of the vicinity of the recessed portion of the front piece surrounded by the dotted circle VIIB.
[0030] Figure 8 It is a schematic plan view showing the structure of the front member and the absorbent body (dashed line) of the disposable diaper according to the second embodiment.
[0031] Fig. 9 It is a schematic partial cross-sectional view of the vicinity of the recessed portion of the front member of the disposable diaper according to the third embodiment of the present invention.
[0032] Fig.10 (A) is a schematic plan view showing the structure of a front member and an absorbent body (dashed line) constituting a part of a disposable diaper of a fourth embodiment of the present invention, and (B) is a schematic cross-sectional view of the disposable diaper of the fourth embodiment, corresponding to Figure 2 A cross-sectional view taken along line IIIA-IIIA. DETAILED DESCRIPTION
[0033] In absorbent articles using antimicrobial agents, since the antimicrobial agents are difficult to dissolve in water, excretion fluids such as urine pass through the front sheet (front material) before the antimicrobial performance is fully exerted, which makes it difficult to exhibit efficient antimicrobial performance.
[0034] The present invention relates to an absorbent article capable of exhibiting highly efficient antimicrobial performance.
[0035] Hereinafter, the absorbent article of the present invention will be described by taking a disposable diaper as an example with reference to the drawings.
[0036] [Overall structure of disposable diapers]
[0037] exist Figure 1 and Figure 2 1A, 1B, 1C are shown as absorbent articles according to the embodiments of the present invention. Hereinafter, the underpants-type disposable diapers 1 (1A, 1B, 1C) are referred to as diapers 1 (1A, 1B, 1C).
[0038] Figure 3 A diaper 1 according to a first embodiment is shown. Figure 7 A diaper 1A according to a second embodiment is shown. Fig. 9 A diaper 1B according to a third embodiment is shown. Fig.10 A diaper 1C according to a fourth embodiment is shown.
[0039] The overall structure of the disposable diaper common to each embodiment will be described below.
[0040] The diaper 1 (1A, 1B, 1C) has a longitudinal direction X corresponding to the front-back direction of the wearer and a transverse direction Y corresponding to the left-right direction of the wearer and perpendicular to the longitudinal direction X. The diaper 1 (1A, 1B, 1C) has a thickness direction Z perpendicular to both the longitudinal direction X and the transverse direction Y.
[0041] In this specification, regarding the transverse direction Y, the side closer to the longitudinal center line CL that bisects the diaper 1 (1A, 1B, 1C) in the transverse direction Y is referred to as the "transverse direction Y inner side", and the side farther from the longitudinal center line CL is referred to as the "transverse direction Y outer side".
[0042] In this specification, when observing each structure from the thickness direction Z, it is referred to as a top view (planar observation). In addition, in this specification, the skin side in each structure means the side located on the skin side of the wearer when the disposable diaper is worn. The non-skin side in each structure means the side opposite to the skin side of the wearer when the disposable diaper is worn. In addition, with respect to the thickness direction Z, the side close to the skin of the wearer when worn is sometimes referred to as the upper side, and the side close to the clothes worn is sometimes referred to as the lower side.
[0043] like Figure 1 and Figure 2 As shown, the diaper 1 (1A, 1B, 1C) includes a waist opening 1W and a pair of leg openings 1L, and is arranged around the waist and crotch of the wearer when worn.
[0044] The diaper 1 (1A, 1B, 1C) is divided into a ventral region A disposed on the ventral side of the wearer when worn, a dorsal region B disposed on the dorsal side of the wearer when worn, and a crotch region C located between the ventral region A and the dorsal region B and disposed at the crotch of the wearer when worn. The ventral region A, the crotch region C, and the dorsal region B are disposed along the longitudinal direction X. The side edges A1 and B1 of the ventral region A and the dorsal region B in the transverse direction Y are joined to each other to form a waist opening 1W. A leg circumference is formed in the crotch region C, and the leg circumference forms a leg opening 1L.
[0045] in addition, Figure 2 The diaper 1 (1A, 1B, 1C) is unfolded to stretch the elastic components of each part and unfold it in a planar manner to a design size completely eliminating the influence of the elastic components. The diaper 1 (1A, 1B, 1C) is unfolded by separating the side edge A1 of the ventral region A and the side edge B1 of the dorsal region B.
[0046] exist Figure 2 , Figure 3 , Figure 7 , Fig. 9 and Fig.10In the example shown, the diaper 1 (1A, 1B, 1C) has a front member (also called a top sheet) 2 (2A), an absorbent body 4 (4C), a side sheet 5, a leak-proof sheet 3 as a back member (also called a back sheet), and an exterior member 6. The diaper 1 (1A, 1B, 1C) has a structure in which the exterior member 6, the leak-proof sheet 3, the absorbent body 4 (4C), and the front member 2 (2A) are stacked in the thickness direction Z. These components are joined to each other by a known joining means such as a hot melt adhesive.
[0047] The absorber 4 (4C) is arranged across the ventral region A, the crotch region C, and the dorsal region B. The absorber 4 (4C) absorbs liquid excrement such as water contained in urine and feces of the wearer from the surface of the front member 2 (2A) side, diffuses it inside, and retains the liquid excrement.
[0048] In this specification, "excrement" refers to all excrement of the wearer including solid components of feces, and "liquid excrement" refers to liquid excrement such as urine in excrement and water in feces.
[0049] The absorbent body 4 ( 4C) includes an absorbent core 40 ( 40C) and a backing paper (core wrapping paper) 41 .
[0050] The absorber 4 (4C) has a skin side ( Figure 3 , Figure 7 and Fig. 9 Reference numerals 4a, Fig.10 Reference numeral 4Ca in the figure and non-skin side ( Figure 3 , Figure 7 and Fig. 9 Reference numerals 4b, Fig.10 Figure 4Cb).
[0051] The absorbent core 40 (40C) is mainly composed of an absorbent material capable of retaining liquid excrement. Specifically, the absorbent core 40 (40C) has a fiber stack of hydrophilic fibers, a structure in which an absorbent polymer is carried on the fiber stack, or a structure composed only of a water-absorbent polymer.
[0052] The absorbent core 40 (40C) has a skin side ( Figure 3 , Figure 7 and Fig. 9 Reference numerals 40a, Fig.10 Reference numeral 40Ca in the figure and the non-skin side ( Figure 3 , Figure 7 and Fig. 9 Reference numeral 40b, Fig.10 Figure 40Cb).
[0053] The backing paper 41 covers the absorbent core 40 (40C) and has, for example, a function of maintaining the shape of the absorbent core 40 (40C). The backing paper 41 is formed of, for example, thin and soft paper such as tissue paper, liquid-permeable nonwoven fabric, or the like.
[0054] The backing paper 41 includes an upper backing paper (skin-side backing paper) 411 and a lower backing paper (non-skin-side backing paper) 412 .
[0055] The upper backing paper 411 covers the skin side 40 a ( 40Ca) of the absorbent core 40 ( 40C) including the slit portion 42 .
[0056] The lower backing paper 412 covers the non-skin side 40 b ( 40Cb) of the absorbent core 40 ( 40C) including the slit portion 42 .
[0057] In the present embodiment, an example is given in which the upper backing paper 411 and the lower backing paper 412 of the backing paper 41 constitute a continuous sheet, but the upper backing paper 411 and the lower backing paper 412 may be separate sheets. Typically, the backing paper 41 is composed of a continuous rectangular backing paper, and when covering the absorbent core 40 (40C), a pair of opposite ends extending in the longitudinal direction X of the backing paper are arranged so as to overlap each other and be located on the non-skin side. The region where the pair of ends overlap each other is typically located in the center of the transverse direction Y of the absorbent body 4 (4C), and overlaps with the slit portion 42 when viewed from above.
[0058] The front member 2 (2A) is arranged so as to contact the skin of the wearer when the diaper 1 is worn. The front member 2 (2A) is arranged at least on the skin side (upper side in the thickness direction Z) of the absorbent body 4 (4C). Figure 3 In the example shown, the front member 2 ( 2A) is arranged so as to extend from the skin side of the absorbent body 4 ( 4C) to the side edge portion in the transverse direction Y and to wrap around the non-skin side of the absorbent body 4 .
[0059] The front material 2 (2A) is configured as a liquid-permeable sheet and is formed of a nonwoven fabric or the like containing synthetic fibers or natural fibers.
[0060] The front member 2 (2A) has a skin side ( Figure 3 , 9 and 2a in the figure 10, Figure 7 2Aa in the figure and the non-skin side ( Figure 3 , 9 and reference numeral 2b in 10, Figure 7 2Ab in the figure).
[0061] In this embodiment, the front member 2 (2A) contains a metal oxide antimicrobial agent from the viewpoint of exerting an antimicrobial effect on excrement. The detailed structures of the front member 2 (2A) and the metal oxide antimicrobial agent will be described later.
[0062] The outer covering 6 is arranged on the non-skin side (below the thickness direction Z) of the absorbent body 4 (4C), for example, constituting substantially the entire non-skin side of the diaper 1 (1A, 1B, 1C). The outer covering 6 is preferably leakproof, for example, formed of a sheet having functions such as low liquid permeability, water vapor permeability, and water repellency.
[0063] exist Figure 3 (A) Figure 7 (A) Fig.10 In the example shown in (B) of FIG. 8 , the exterior member 6 includes a skin side sheet 61 and a non-skin side sheet 62 .
[0064] like Figure 1 and Figure 2 As shown, the outer member 6 forms a waist opening 1W and a leg opening 1L. The outer member 6 also includes a waist elastic member 63 arranged along the waist opening 1W and a leg elastic member 64 arranged along the leg opening 1L. The waist elastic member 63 and the leg elastic member 64 are arranged, for example, between the skin side sheet 61 and the non-skin side sheet 62.
[0065] The pair of side sheets 5 are arranged on the skin side of the lateral Y side of the front member 2 (2A). The side sheets 5 are preferably leakproof and are formed of a sheet material having functions such as low liquid permeability, water vapor permeability, and water repellency. Figure 3 (A) Figure 7 (A) and Fig.10 In the example shown in (B), the side sheet 5 extends from the side portion on the transverse direction Y of the skin side of the front member 2 (2A) to the non-skin side of the front member 2 (2A). The end of the skin side of the side sheet 5 is spaced apart from the front member 2 (2A). The end of the non-skin side of the side sheet 5 is joined to the leakproof sheet 3, etc. together with the end of the non-skin side of the front member 2 by adhesive or heat sealing.
[0066] In the diaper 1, a linear or belt-shaped elastic member 51 is disposed at the skin-side end of the side panel 5. The elastic member 51 extends in the longitudinal direction X and is attached to the side panel 5 in a stretched state. Thus, when worn, the skin-side end of the side panel 5 stands up toward the skin side, forming three-dimensional gathers G.
[0067] The leak-proof sheet 3 is formed of a liquid-impermeable or liquid-impermeable resin film, and is disposed on the non-skin side of the absorbent body 4 (4C), and between the absorbent body 4 (4C) and the exterior member 6. The leak-proof sheet 3 is bonded to the non-skin side of the absorbent body 4 (4C) by, for example, an adhesive (not shown), and is bonded to the exterior member 6 by an adhesive (not shown).
[0068] <First Embodiment>
[0069] [Structure of absorber]
[0070] As described above, the absorbent body 4 is composed of the absorbent core 40 and the backing paper 41 .
[0071] like Figure 4 As shown, the absorbent core 40 constituting a part of the absorber 4 extends in the longitudinal direction X in the crotch region C and has a slit 42 in the center in the transverse direction Y. The center in the transverse direction Y of the absorbent core 40 refers to the region on the longitudinal center line CL which divides the diaper 1 in the transverse direction Y into two equal parts.
[0072] The slit 42 has an elongated shape having a predetermined width in a plan view and is a through hole that penetrates the absorbent core 40 in the thickness direction Z. The slit 42 is a groove without a bottom and is typically a region where the material forming the absorbent core does not exist.
[0073] The slit portion 42 functions as a flow path for excreta such as urine, promotes the diffusion of excreta in the surface direction along the extending direction of the slit portion 42, and contributes to the effective use of the liquid absorption performance of the absorbent body 4. Since the slit portion 42 plays such a role, it is preferably arranged at a portion of the absorbent core 40 where excreta are easily concentrated. From such a viewpoint, the slit portion 42 is preferably arranged at a portion located in the crotch region C of the absorbent core 40. In addition, the slit portion 42 may extend to at least one of the ventral region A or the dorsal region B. In addition, the slit portion 42 of the present embodiment is a structure extending in the longitudinal direction X, but is not limited to this structure, and may also be a structure extending in the transverse direction Y, or a structure extending in a direction including both the longitudinal X component and the transverse Y component.
[0074] The slits 42 also function as deformation guides when the absorbent core 40 is deformed such as bending due to external forces such as body pressure, thereby promoting deformation along the wearer's body shape, reducing discomfort when the diaper 1 is worn, and improving wearing comfort and fit.
[0075] The slit 42 extending in the longitudinal direction X is not limited to extending in parallel with the longitudinal direction X, and may extend from the ventral side to the dorsal side as a whole. For example, the slit 42 may be configured in a curved shape.
[0076] The shape of the slit portion 42 in a plan view may be an elongated shape and is not particularly limited. Figure 4 In the example shown, the slit portion 42 is configured in a linear (belt) shape, and the dimension of the slit portion 42 in the width direction (lateral direction Y) perpendicular to the extending direction is substantially constant, but the dimension in the width direction may vary along the extending direction.
[0077] In addition, in this embodiment and the second and third embodiments described later, an example is given in which the number of the slit portions 42 is set to one, but it may be set to two as in the fourth embodiment described later, and the absorbent body may also have a plurality of slit portions 42. In the case of having a plurality of slit portions 42, typically, a plurality of slit portions having a length direction in the longitudinal direction X are arranged at intervals in the transverse direction Y, and the plurality of slit portions are formed symmetrically with respect to the longitudinal center line CL, but may also be formed asymmetrically. In addition, the shapes and sizes of the plurality of slit portions 42 when viewed from above may be the same as each other or different from each other.
[0078] The length of the longitudinal direction X of the slit 42 is preferably 20% to 70%, particularly preferably 30% to 60% of the length (total length) of the absorbent core in the longitudinal direction X. For example, when the total length of the absorbent core in the longitudinal direction X is 370 mm, the length of the longitudinal direction X of the slit 42 can be set to 140 mm.
[0079] The length of the slit 42 in the transverse direction Y is preferably 2% to 20%, particularly preferably 4% to 10%, of the maximum length (maximum width) of the absorbent core in the transverse direction Y. For example, when the maximum width of the absorbent core is 120 mm, the width of the slit 42 can be set to 5 mm.
[0080] The absorbent core 40 is a component constituting the main body of the absorbent body 4, and is composed of a water-absorbent material. Examples of the water-absorbent material include water-absorbent fibers and water-absorbent polymers, and one of them can be used alone or in combination of two or more. The absorbent core 40 is typically composed of a fiber aggregate containing water-absorbent fibers, or a form in which a granular water-absorbent polymer is retained in the fiber aggregate.
[0081] The absorbent core 40 having the slit portion 42 can be produced according to a conventional method using, for example, a known fiber deposition device having a rotating drum.
[0082] like Figure 3 As shown in (A) and (B), in the absorber 4, the upper backing paper 411 is joined to the lower backing paper 412 at the slit portion 42. Therefore, the skin side 4a of the absorber 4 has an absorber skin side concave portion 45a formed by the upper backing paper 411 and the lower backing paper 412 joined to each other along the shape of the slit portion 42 and concave toward the non-skin side.
[0083] In this way, by joining the upper layer backing paper 411 and the lower layer backing paper 412 at the slit portion 42 , the absorbent body skin side recessed portion 45 a can be reliably formed on the skin side surface 4 a of the absorbent body 4 .
[0084] In addition, in this embodiment, if Figure 3As shown in (A) and (B), the absorbent body 4 has an absorbent body non-skin side recess 45b on its non-skin side 4b, which is formed along the shape of the slit portion 42 and is recessed toward the skin side by the upper layer backing paper 411 and the lower layer backing paper 412 joined to each other.
[0085] like Figure 3 As shown in (B) of FIG. 1 , in the diaper 1 , a space S is formed by the absorbent body non-skin side recess 45 b between the lower layer backing paper 412 and the leakage-barrier sheet 3 as the backing member at a position corresponding to the slit portion 42 .
[0086] The upper backing paper 411 and the lower backing paper 412 in the slit portion 42 can be joined by applying an adhesive (not shown) between the backing paper 41 and the absorbent core 40 and pressing the absorbent core 40 covered by the backing paper 41 in the thickness direction Z using a pressing roller. Thus, an absorbent body skin side recess 45a is formed on the skin side 4a of the absorbent body 4.
[0087] When the leakage preventing sheet 3 and the absorbent body 4 are bonded together using an adhesive, the space S can be formed by positioning the adhesive-free non-applied portion where no adhesive is present in at least a portion of the formation range of the slit 42 in a plan view.
[0088] From the perspective of setting the space S to a larger range, in the top view of the slit portion 42, the ratio of the adhesive non-coated portion to the plane area of the slit portion 42 (the area of the formation range of the slit portion) is preferably 30% or more, more preferably 50% or more.
[0089] The adhesive disposed between the upper backing paper 411 and the absorbent core 40 and the adhesive disposed between the lower backing paper 412 and the absorbent core 40 are applied, for example, in a plan view over the entire overlapping region of the two in an intermittent pattern in which adhesive-applied portions and adhesive-unapplied portions are alternately arranged in the longitudinal direction X and the lateral direction Y. The application pattern is not limited thereto.
[0090] Typically, the adhesive is applied in a manner such that a plurality of spiral adhesives extending along the conveyance direction (corresponding to the longitudinal direction X of the product) during manufacture of the absorbent body 4 are arranged at intervals in a direction perpendicular to the conveyance direction.
[0091] The adhesive disposed between the leakage-preventing sheet 3 and the absorbent body 4 is applied, for example, over the entire overlapping region of the two in a plan view in an intermittent pattern in which adhesive-applied portions and adhesive-unapplied portions are alternately arranged in the longitudinal direction X and the lateral direction Y. The application pattern is not limited thereto.
[0092] Typically, the adhesive is applied in a manner that a plurality of spiral adhesives extending along the conveying direction of the absorbent body 4 during manufacture (the longitudinal direction X of the absorbent core when manufactured into a diaper) are arranged at intervals in a direction perpendicular to the conveying direction.
[0093] [Structure of the front part]
[0094] The front member 2 is composed of one or more sheets containing fibers. As the sheet, for example, various nonwoven fabrics such as nonwoven fabrics manufactured by a carding method, spunbonded nonwoven fabrics, meltblown nonwoven fabrics, spunlace nonwoven fabrics, and needle-punched nonwoven fabrics can be used.
[0095] like Figure 3 As shown in (A) and (B) of FIG. 1 , the front piece 2 is arranged so as to cover the skin side 4a of the absorber 4. As described above, on the skin side 4a of the absorber 4, an absorber skin side recess 45a that is recessed toward the non-skin side is formed along the shape of the slit portion 42. The front piece 2 is arranged so as to cover the absorber skin side recess 45a in a manner roughly along the shape of the absorber skin side recess 45a. Thus, on the skin side 2a of the front piece 2, a front piece recess 20 is formed at a position corresponding to the slit portion 42.
[0096] Due to the concave shape, excrement such as urine and feces can be easily accumulated in the concave portion 20 of the front member.
[0097] The front material 2 contains a metal oxide antimicrobial agent. The metal oxide antimicrobial agent is contained in the fiber. More specifically, the metal oxide antimicrobial agent is mixed with the fiber. The fiber mixed with the antimicrobial agent is called a metal oxide antimicrobial agent mixed (blended) fiber.
[0098] The metal oxide antimicrobial agent mixed fiber may be a fiber in which the metal oxide antimicrobial agent is present inside the fiber, or a part of the metal oxide antimicrobial agent may be exposed on the surface. For example, when the metal oxide antimicrobial agent mixed fiber is a core-sheath type composite fiber, the metal oxide antimicrobial agent may be contained only in one of the core and sheath of the fiber, or in both the core and sheath.
[0099] As the metal oxide antibacterial agent, zinc oxide, silver oxide, aluminum oxide, calcium oxide, magnesium oxide, copper oxide, etc. can be used. These metal oxides can be used alone or in combination of two or more. The metal oxide antibacterial agent of the present embodiment preferably contains zinc oxide from the perspective of their antibacterial properties, safety, and price.
[0100] Since the metal oxide antimicrobial agent has low solubility in water, even if the metal oxide antimicrobial agent comes into contact with liquid excreta such as urine, it is unlikely to fall off in a short period of time.
[0101] Furthermore, the metal oxide antimicrobial agent mixed fiber is formed by kneading the metal oxide antimicrobial agent into the fiber, and thus the metal oxide antimicrobial agent can be effectively prevented from falling off the fiber even when it comes into contact with liquid excrement.
[0102] As a result, the metal oxide antibacterial agent easily stays on the front member 2.
[0103] like Figure 3 (A) and Figure 4 As shown, the front member 2 has a first region 21 and a second region 22 having different mixing amounts of the metal oxide antimicrobial agent.
[0104] The first region 21 overlaps with the central region 43 of the absorbent body 4 in a plan view and contains a metal oxide antimicrobial agent. The first region 21 may overlap with at least a portion of the central region 43 in a plan view, but preferably overlaps with the entire central region 43. Figure 4 In the example shown, the first region 21 extends over the entire length of the longitudinal direction X of the front member 2. Figure 4 In the example shown, the side edge portion of the first region 21 in the transverse direction Y is configured in a straight line, but may include a curved portion.
[0105] The second region 22 is located outside the first region 21 in the transverse direction Y. The second region overlaps at least a portion of the side region 44 of the absorbent body 4 when viewed from above. Figure 4 In the example shown, the second region 22 extends over the entire length in the longitudinal direction X of the front member 2 , similarly to the first region 21 .
[0106] The second region 22 contains a smaller amount of the metal oxide antimicrobial agent than the first region 21 .
[0107] In addition, in this specification, the expression "the mixed amount of the metal oxide antimicrobial agent in a certain area is small" also includes a mode in which the metal oxide antimicrobial agent is not contained in the area.
[0108] In other words, the second region 22 has a structure that contains a metal oxide antimicrobial agent in a smaller amount than that of the first region 21, or a structure that does not contain a metal oxide antimicrobial agent.
[0109] When a metal oxide antimicrobial agent mixed fiber is used in the front member 2, the mixing amount of the metal oxide antimicrobial agent in the first region 21 and the second region 22 can be adjusted by, for example, the mixing amount of the metal oxide antimicrobial agent mixed fiber. For example, the mass proportion of the metal oxide antimicrobial agent mixed fiber in the first region 21 can be greater than the mass proportion of the metal oxide antimicrobial agent mixed fiber in the second region 22.
[0110] Alternatively, metal oxide antimicrobial agent mixed fibers having different mixing ratios of the metal oxide antimicrobial agent may be used in the first region 21 and the second region 22. For example, the mixing ratio of the metal oxide antimicrobial agent in the metal oxide antimicrobial agent mixed fibers contained in the first region 21 may be greater than the mixing ratio of the metal oxide antimicrobial agent in the metal oxide antimicrobial agent mixed fibers contained in the second region 22.
[0111] In this embodiment, the first region 21 has a fiber layer containing metal oxide antimicrobial agent mixed fibers, and the second region 22 does not have a fiber layer containing metal oxide antimicrobial agent mixed fibers, thereby adjusting the mixing amount of the metal oxide antimicrobial agent in the first region 21 to be greater than that in the second region 22. The detailed structure is described later.
[0112] like Figure 3 As shown in (A) and (B) of FIG. 1 , the front member recess 20 is composed of the first region 21. In other words, in the front member 2, a relatively large amount of the metal oxide antimicrobial agent exists in the front member recess 20.
[0113] The front member recess 20 formed on the skin side 2a of the front member 2 and recessed toward the non-skin side substantially along the shape of the absorbent skin side recess 45a can be typically formed by applying an adhesive between the front member 2 and the upper backing paper 411 and pressing the absorbent skin side recess 45a joined to the front member 2 in the thickness direction Z using a pressing roller. In addition, the manufacturing method is not limited to the method described herein.
[0114] [Effects of this embodiment]
[0115] In this embodiment, in the front member recess 20, due to its shape, excreta such as urine and feces are easily accumulated. Since the structure is configured such that a relatively large amount of metal oxide antimicrobial agent is present in the front member recess 20 where the excreta are easily accumulated, the contact time between the excreta accumulated in the front member recess 20 and the metal oxide antimicrobial agent becomes longer, and sufficient time for the metal oxide antimicrobial agent to dissolve can be ensured. As a result, it is possible to suppress the transfer of liquid excreta to the absorbent body 4 side before the metal oxide antimicrobial agent dissolves, and the amount of metal oxide antimicrobial agent dissolved in the liquid excreta can be increased.
[0116] Moreover, the metal oxide antimicrobial agent contained in the front part 2 is composed of metal oxides with low solubility in water, so that the metal oxide antimicrobial agent gradually dissolves into the liquid excreta accumulated in the front part recess 20, thereby preventing the antimicrobial agent from falling off from the front part 2 in a short time, thereby enabling the high-frequency contact between the excreta accumulated in the front part recess 20 and the metal oxide antimicrobial agent to continue. In addition, since the metal oxide antimicrobial agent is mixed with the fiber, it is not easy to fall off and move to other layers, thereby enabling the high-frequency contact between the excreta accumulated in the front part recess 20 and the metal oxide antimicrobial agent to continue longer. Thus, a highly efficient and effective antimicrobial effect can be obtained, and the antimicrobial effect on bacteria from excreta can be improved.
[0117] Furthermore, by mixing the metal oxide antibacterial agent in the front member 2, an antibacterial effect can be exerted directly on the excrement in contact with the skin. Thus, skin rashes caused by bacteria from excrement can be effectively suppressed.
[0118] A portion of the first region 21 constitutes a front member recess 20 that is not easy to contact the wearer's skin. On the other hand, the second region 22 is an area that is easy to directly contact the wearer's skin. In the front member 2, by providing an area (second region 22) in which the amount of metal oxide antimicrobial agent mixed is relatively small, it is also possible to suppress skin rashes caused by an imbalance of skin resident bacteria caused by excessive metal oxide antimicrobial agent.
[0119] As described above, according to this embodiment, the antibacterial effect of the metal oxide antibacterial agent can be effectively exerted, and the amount of the metal oxide antibacterial agent mixed in the entire front member 2 can be reduced. As a result, a diaper (absorbent article) 1 that exerts an antibacterial effect gently on the skin can be realized at low cost.
[0120] In addition, in this embodiment, if Figure 3 As shown in (B) of FIG. 4 , in the slit portion 42 , a space S is formed between the lower layer backing paper 412 and the leakage preventing sheet (back member) 3 .
[0121] The liquid excrement accumulated in the recessed portion 20 of the front member and in which the metal oxide antibacterial agent is dissolved is transferred to the absorbent core 40 through the front member 2 and the upper backing paper 411, or is transferred to the space S through the upper backing paper 411 and the lower backing paper 412 joined to each other. The liquid excrement in which the metal oxide antibacterial agent is dissolved that has been transferred to the space S is rapidly transferred to the absorbent core 40 through the lower backing paper 412. The liquid excrement in which the metal oxide antibacterial agent is dissolved is absorbed in the absorbent core 40, thereby being able to exert an antibacterial effect.
[0122] [Example of the configuration of a two-layer front member]
[0123] In this embodiment, from the perspective of easily adjusting the mixing amount of the metal oxide antibacterial agent in the first region 21 and the second region 22, as shown in FIG. Figure 3 (A) and Figure 4 As shown, the front member 2 includes an upper layer 23 containing a metal oxide antimicrobial agent and a lower layer 24 containing a smaller amount of the metal oxide antimicrobial agent than the upper layer 23. In the front member 2, the upper layer 23 is located on the skin side, and the lower layer 24 is located on the non-skin side.
[0124] The first region 21 includes the upper layer 23. The second region 22 includes the lower layer 24 and does not include the upper layer 23. In other words, in the front member 2, the region including the upper layer 23 having a large mixing amount of the metal oxide antimicrobial agent is defined as the first region 21, and the region not including the upper layer 23 in the front member 2 is defined as the second region 22.
[0125] like Figure 3 As shown in (A), the first region 21 preferably includes an overlapping region 27 where the upper layer 23 and the lower layer 24 overlap when viewed from above, that is, includes a multilayer structure. Moreover, in this embodiment, the overlapping region 27 is preferably configured in the entire first region 21. That is, in Figure 3 In the example shown in (A), the lower layer 24 is continuously arranged on the entire front member 2 in a plan view, and the upper layer 23 is arranged on the lower layer 24 in the central part in the horizontal direction Y.
[0126] By forming the first region 21 of the front material 2 into a multi-layer structure in this manner, the absorption of liquid excrement in the front material recess 20 formed by the first region 21 becomes smoother.
[0127] That is, Figure 3 As shown in (A) and (B), since the front part recess 20 is composed of a multi-layer structure, the liquid components of the excrement 30 such as feces and urine located in the front part recess 20 are absorbed smoothly by the absorbent 4. In other words, the liquid excrement is easily accumulated in the front part recess 20 for a long time. Therefore, the excrement 30 in the front part recess 20 can be in contact with the metal oxide antibacterial agent of the first area 21 constituting the front part recess 20 for a longer period of time. Therefore, it is possible to ensure that the metal oxide antibacterial agent dissolves into the liquid excrement for a longer time, and can more reliably exert the antibacterial effect.
[0128] The front material 2 including the upper layer 23 and the lower layer 24 may be a sheet material obtained by joining two nonwoven fabric sheets to form an integrated sheet. In this case, for example, the front material 2 can be formed by joining two nonwoven fabric sheets by embossing, adhesive or the like.
[0129] Alternatively, the front member 2 including the upper layer 23 and the lower layer 24 may be a nonwoven fabric sheet including two fiber layers. In this case, for example, fiber webs composed of different fibers are overlapped and the fibers of each layer are fused by heat treatment such as hot air processing, thereby forming the front member 2.
[0130] When the fibers of each layer are melted and fused by heating the upper layer 23 and the lower layer 24, the melted and fused portion (molten resin) tends to be difficult to absorb liquid excrement, and the absorption of liquid excrement becomes smoother. By including such a molten resin in the first area 21 constituting the front member recess 20, the accumulation time of the excrement 30 in the front member recess 20 can be further prolonged. As a result, the metal oxide antimicrobial agent in the first area 21 constituting the front member recess 20 can effectively contact the excrement 30 and can more reliably exert the antimicrobial effect.
[0131] like Figure 5 As shown in the enlarged view of , the upper layer 23 and the lower layer 24 of the present embodiment are preferably different fiber layers in one nonwoven fabric sheet.
[0132] In addition, Figure 5 In FIG. 1 , the metal oxide antimicrobial agent mixed fiber 25 is represented by a line with only a white outline inside. The metal oxide antimicrobial agent non-mixed fiber 26, which is a fiber that does not contain a metal oxide antimicrobial agent, is represented by a line with a filled inside. Figure 6 In the figure, a small circle with a white interior and only a contour line and a small circle with a black interior both schematically represent a fusion zone between fibers.
[0133] In this embodiment, the proportion of the mass of the metal oxide antimicrobial agent mixed fiber 25 in the overall mass of the upper layer 23 is greater than the proportion of the mass of the metal oxide antimicrobial agent mixed fiber 25 in the overall mass of the lower layer 24. That is, the upper layer 23 contains the metal oxide antimicrobial agent mixed fiber 25, and the lower layer 24 contains no metal oxide antimicrobial agent mixed fiber 25, or contains a smaller proportion of the metal oxide antimicrobial agent mixed fiber 25 than the upper layer 23.
[0134] From the viewpoint of sufficiently obtaining the antibacterial effect on excrement, the proportion of the metal oxide antibacterial agent mixed fiber 25 in the entire upper layer 23 is preferably 30 mass % or more, more preferably 80 mass % or more, and even more preferably 100 mass %.
[0135] From the viewpoint of reducing the effect of the metal oxide antimicrobial agent on skin resident bacteria, the proportion of the metal oxide antimicrobial agent mixed fiber 25 in the entire lower layer 24 is preferably 50 mass % or less, more preferably 30 mass % or less, and even more preferably 0 mass %.
[0136] In this embodiment, if Figure 5 As shown, it is more preferred that the upper layer 23 only contains the metal oxide antibacterial agent mixed fiber 25 as a fiber component, and the lower layer 24 only contains the metal oxide antibacterial agent non-combined fiber 26 as a fiber component. Thus, it is possible to form a structure that contains more metal oxide antibacterial agent in the first area 21 and does not contain metal oxide antibacterial agent in the second area 22, which can show a highly efficient antibacterial effect, reduce material costs, and further inhibit skin rashes caused by an imbalance of skin resident bacteria. In addition, the types of fibers used in the upper layer 23 and the lower layer 24 can be limited, and the manufacture of the front member 2 becomes easier.
[0137] [Example of the ratio of metal oxide antimicrobial agent mixed fiber in the front material]
[0138] From the perspective of efficiently and effectively exerting the antibacterial effect of the metal oxide antibacterial agent on bacteria from excrement accumulated in the recessed portion 20 of the front member, the proportion of the metal oxide antibacterial agent mixed fibers 25 in the first region 21 in the metal oxide antibacterial agent mixed fibers 25 of the entire front member 2 is preferably 30% by mass or more, and more preferably 50% by mass or more.
[0139] In addition, from the perspective of inhibiting the effect of the metal oxide antimicrobial agent 29 on resident bacteria, the proportion of the metal oxide antimicrobial agent mixed fiber 25 in the second region 22 in the metal oxide antimicrobial agent mixed fiber 25 of the entire front part 2 is preferably less than 30 mass %, more preferably less than 10 mass %, and further preferably 0 mass %.
[0140] [Example of the ratio of metal oxide antimicrobial agent to the entire front material]
[0141] From the perspective of efficiently and effectively exerting the antibacterial effect of the metal oxide antibacterial agent on bacteria from excrement accumulated in the recessed portion 20 of the front member, the proportion of the metal oxide antibacterial agent 29 contained in the first region 21 relative to the entire front member 2 is preferably 0.001 mass % or more, more preferably 0.004 mass % or more.
[0142] In addition, from the perspective of inhibiting the effect of the metal oxide antimicrobial agent 29 on resident bacteria, the proportion of the metal oxide antimicrobial agent 29 contained in the second region 22 relative to the entire front member 2 is preferably less than 2.0% by mass, more preferably 0.5% by mass or less, and even more preferably 0% by mass.
[0143] The method for calculating the ratio of the metal oxide antimicrobial agent 29 contained in the first region or the second region to the entire front member will be described later.
[0144] [Example of the composition of metal oxide antimicrobial agent mixed fiber]
[0145] The metal oxide antimicrobial agent mixed fiber 25 can be obtained, for example, by a spinning process of a synthetic resin pre-kneaded with a metal oxide antimicrobial agent.
[0146] The metal oxide antimicrobial agent mixed fiber 25 can be, for example, a single fiber composed of one synthetic resin (thermoplastic resin) or a blended polymer mixed with two or more synthetic resins, or a composite fiber. The composite fiber mentioned here refers to a synthetic fiber (thermoplastic fiber) obtained by combining two or more synthetic resins with different components using a spinneret and spinning them simultaneously. It is a fiber in which multiple components are continuous in the length direction of the fiber and are mutually bonded in a single fiber. The composite fiber has a core-sheath type, a parallel type, etc.
[0147] The metal oxide antimicrobial agent non-mixed fiber 26 may be, for example, a single fiber made of one synthetic resin (thermoplastic resin) or a polymer blend of two or more synthetic resins, or may be a composite fiber.
[0148] From the viewpoint of effectively exhibiting antimicrobial performance, it is preferred that the metal oxide antimicrobial agent is exposed on the surface of the metal oxide antimicrobial agent mixed fiber 25 .
[0149] In this case, from the viewpoint of efficiently exposing the metal oxide antimicrobial agent on the fiber surface, the metal oxide antimicrobial agent mixed fiber 25 is preferably a core-sheath type fiber in which the metal oxide antimicrobial agent is mixed only in the sheath portion.
[0150] like Figure 6 As shown, the metal oxide antimicrobial agent mixed fiber 25 kneaded with the metal oxide antimicrobial agent 29 has a core 25C and a sheath 25S. The metal oxide antimicrobial agent 29 is mixed only in the sheath 25S. In this way, by mixing the metal oxide antimicrobial agent 29 only in the sheath 25S, the metal oxide antimicrobial agent 29 can be easily exposed to the fiber surface with a small amount of the metal oxide antimicrobial agent mixed.
[0151] The core-sheath type metal oxide antimicrobial agent mixed fiber 25 that becomes the raw material fiber can use, for example, a fiber in which the core 25C is composed of PET (polyethylene terephthalate) or PP (polypropylene), the sheath 25S is composed of PE (polyethylene) mixed with a metal oxide antimicrobial agent having a metal oxide, and the core-sheath ratio is 20 / 80 to 80 / 20 in terms of mass ratio. In addition, the core-sheath ratio indicates the mass ratio (core / sheath) of the resins constituting the core and the sheath.
[0152] The particle size of the metal oxide antimicrobial agent 29 is appropriately set from the perspective of the thickness of the fiber (metal oxide antimicrobial agent mixed fiber 25) mixed with the metal oxide antimicrobial agent and the ease of mixing the metal oxide of the fiber. Generally, the average particle size of the metal oxide antimicrobial agent is a volume cumulative particle size D of 50% by volume based on the laser diffraction scattering particle size distribution measurement method. 50 It indicates that the thickness is greater than or equal to 1.0 μm and less than or equal to 7 μm.
[0153] From the perspective of efficiently and effectively exerting the skin problem prevention effect brought about by the metal oxide antibacterial agent 29, the proportion of the metal oxide antibacterial agent 29 in the core-sheath type metal oxide antibacterial agent mixed fiber 25 is preferably 0.05 mass% or more, more preferably 0.1 mass% or more, preferably 2.5 mass% or less, more preferably 2.0 mass% or less, preferably 0.05 mass% or more and 2.5 mass% or less, more preferably 0.1 mass% or more and 2.0 mass% or less.
[0154] The method for calculating the ratio of the metal oxide antimicrobial agent in the metal oxide antimicrobial agent mixed fiber will be described later.
[0155] In addition, in the core-sheath type metal oxide antibacterial agent mixed fiber, in order to more efficiently and effectively exert the skin problem prevention effect produced by the metal oxide antibacterial agent, it is preferred that the metal oxide antibacterial agent is included only in the sheath portion. In the core-sheath type metal oxide antibacterial agent mixed fiber 25, the proportion of the metal oxide antibacterial agent 29 in the resin constituting the sheath portion 25S is preferably 0.1 mass% or more, more preferably 0.2 mass% or more, preferably 5.0 mass% or less, more preferably 4.0 mass% or less, preferably 0.1 mass% or more and 5.0 mass% or less, more preferably 0.2 mass% or more and 4.0 mass% or less.
[0156] [Solubility of Metal Oxide Antimicrobial Agents]
[0157] As described above, from the viewpoint of suppressing the dissolution of the metal oxide antimicrobial agent 29 relative to the liquid excreta and achieving efficient contact between the metal oxide antimicrobial agent 29 and the liquid excreta, the metal oxide antimicrobial agent 29 is preferably poorly soluble in water or insoluble in water. In other words, the solubility of the metal oxide antimicrobial agent 29 in water (the solubility of the metal oxide antimicrobial agent) is preferably low.
[0158] Specifically, the solubility of the metal oxide antibacterial agent is preferably 0.01 g / 100 ml to 0.5 g / 100 ml, more preferably 0.03 g / 100 ml to 0.3 g / 100 ml, and further preferably 0.05 g / 100 ml to 0.2 g / 100 ml in the measurement method of the solubility of the metal oxide antibacterial agent described below.
[0159] <Second Embodiment>
[0160] use Figure 7 and Figure 8 A diaper 1A according to the second embodiment will be described.
[0161] In addition, in this embodiment and the third and fourth embodiments described later, the same reference numerals are given to the existing structures, and the description thereof will be omitted.
[0162] In the second embodiment, only the structure of the front material 2A is different from the structure of the front material 2 of the first embodiment, and therefore the front material 2A will be mainly described.
[0163] When the front material includes an upper layer and a lower layer, the lower layer may be formed discontinuously in the first region. The front material 2A used in the diaper 1A of the present embodiment has a discontinuous shape in the first region.
[0164] like Figure 7 (A) and Figure 8 As shown, in the diaper (absorbent article) 1A of the second embodiment, the front member 2A has, when viewed from above, a lower layer 24L and a lower layer 24R arranged at intervals in the transverse direction Y, and an upper layer 23 located between the lower layer 24L and the lower layer 24R so as to partially overlap the lower layer 24L and the lower layer 24R. The lower layer 24L and the lower layer 24R constitute a discontinuous lower layer.
[0165] As described above, the upper layer 23 contains a metal oxide antimicrobial agent, and the mixing amount of the metal oxide antimicrobial agent is greater than that of the lower layers 24L and 24R. In this embodiment, the area of the front member 2A containing the upper layer 23 is set as the first area 21A, and the area of the front member 2A not containing the upper layer 23 is set as the second area 22.
[0166] The first area 21A of the front member 2A includes a non-overlapping area 28 including the upper layer 23 and excluding the lower layers 24L and 24R. In the non-overlapping area 28, the upper layer 23 and the lower layers 24L and 24R do not overlap in a plan view.
[0167] The first region 21A includes an overlapping region 27 where the upper layer 23 and the lower layers 24L and 24R overlap in a plan view at the side portion in the lateral direction Y. The fibers of the upper layer 23 and the lower layers 24L and 24R can be fused or joined to each other in the overlapping region 27. Therefore, by providing the overlapping region 27, separation of the upper layer 23 and the lower layers 24L and 24R is suppressed.
[0168] like Figure 7 As shown in (A) and (B), in the present embodiment, as in the first embodiment, a slit portion 42 is formed in the absorbent core 40, and the upper layer lining paper 411 and the lower layer lining paper 412 are joined at the slit portion 42, so that an absorbent body skin side recess 45a formed by the slit portion 42 and recessed toward the non-skin side can be reliably formed on the skin side 4a of the absorbent body 4.
[0169] In addition, the absorber 4 has an absorber non-skin side recess 45b on its non-skin side 4b. In the diaper 1, a space S is formed between the lower liner 412 and the leakproof sheet 3 as a back member at a position corresponding to the slit 42 by the absorber non-skin side recess 45b.
[0170] In addition, a front material recess 20 is formed in the skin-facing side 2Aa of the front material 2A.
[0171] The liquid excrement accumulated in the recessed portion 20 of the front member and in which the metal oxide antibacterial agent is dissolved is transferred to the absorbent core 40 through the front member 2 and the upper backing paper 411, or is transferred to the space S through the upper backing paper 411 and the lower backing paper 412 joined to each other. The liquid excrement in which the metal oxide antibacterial agent is dissolved that has been transferred to the space S is rapidly transferred to the absorbent core 40 through the lower backing paper 412. In the absorbent core 40, the liquid excrement in which the metal oxide antibacterial agent is dissolved is absorbed, and an antibacterial effect can be exerted.
[0172] like Figure 7 and Figure 8 As shown, the non-overlapping region 28 (region where no lower layer exists) between the lower layer 24L and the lower layer 24R overlaps with the slit portion 42 in a plan view.
[0173] like Figure 7 As shown in (A) and (B) of FIG. 1 , in the present embodiment, the front member recess 20 includes a multilayer structure in which lower layers 24L and 24R overlap with an upper layer 23. More specifically, in the example shown in the figure, the side surface in the inner surface of the front member recess 20 has a multilayer structure, and the bottom surface in the inner surface of the front member recess 20 has a single-layer structure of only the upper layer 23.
[0174] According to such a structure, similarly to the first embodiment, in the front member 2A, the front member recess 20 is formed by the first region 21A where a relatively large amount of the metal oxide antimicrobial agent exists. Since a large amount of the metal oxide antimicrobial agent exists in the front member recess 20 where excrement is easily accumulated, the antimicrobial effect on bacteria from excrement can be efficiently exerted. In addition, by reducing the mixing amount of the metal oxide antimicrobial agent in the second region 22, the adverse effect on the resident bacteria of the skin can be suppressed.
[0175] Furthermore, by making a part of the inner surface of the front member recess 20 into a multi-layer structure, the excrement 30 such as feces and urine in the front member recess 20 is smoothly absorbed by the absorbent body 4. As a result, liquid excrement is easily accumulated in the front member recess 20 for a long time, and the metal oxide antimicrobial agent can be dissolved into the liquid excrement for a longer time, so that the antimicrobial effect can be more reliably exerted.
[0176] As described above, the lower layer of the front member may be formed discontinuously and provided with the non-overlapping region 28, thereby reducing the material cost of the lower layers 24L and 24R compared to the first embodiment. Therefore, the diaper 1A can be manufactured at a lower cost.
[0177] <Third Embodiment>
[0178] In the first and second embodiments, an example is given in which the lower lining paper 412 and the leakproof sheet 3 are separated from each other to form a space S therebetween. In contrast, the lower lining paper 412 and the leakproof sheet 3 may be joined at a position corresponding to the slit portion 42 without forming a space S, which is described below as a third embodiment. The front member 2 used in the diaper 1C of this embodiment has the same structure as the front member 2 described in the first embodiment, which is described below.
[0179] like Fig. 9 As shown, in the diaper 1B of this embodiment, similarly to the above-mentioned embodiments, a slit portion 42 is formed in the absorbent core 40. By joining the upper layer backing paper 411 and the lower layer backing paper 412 at the slit portion 42, an absorbent body skin side recessed portion 45a that is concave toward the non-skin side and follows the shape of the slit portion 42 is reliably formed on the skin side 4a of the absorbent body 4.
[0180] Furthermore, in the diaper 1B of the present embodiment, the lower liner 412 is joined to the leak-proof sheet 3, and the absorbent non-skin side recess 45b is not formed in the absorbent 4, and the space S is not formed. Therefore, the recess depth of the absorbent skin side recess 45a in the thickness direction Z is deeper than the recess depth of the absorbent skin side recess 45a in the first and second embodiments, and the area of the inner surface becomes larger.
[0181] Since the front member 2 is provided along such an absorbent body skin-side recess 45a, the front member recess 20 has a deeper recess depth in the thickness direction Z and a larger inner surface area than the front member recess 20 of the first and second embodiments.
[0182] Therefore, in the recessed portion 20 of the front part formed by the first area 21 where the metal oxide antibacterial agent is relatively present, the contact range between the excrement and the metal oxide antibacterial agent can be expanded compared to the first and second embodiments, and the amount of the metal oxide antibacterial agent dissolved in the liquid excrement is increased, thereby being able to exhibit a more efficient antibacterial performance.
[0183] In addition, in the present embodiment, the front material concave portion 20 is composed of a multi-layer structure. More specifically, the front material concave portion 20 of the diaper 1B is composed of a multi-layer structure. As a result, liquid excreta can be easily accumulated in the front material concave portion 20 for a long time, and the metal oxide antimicrobial agent can be dissolved into the liquid excreta for a longer time, and the antimicrobial effect can be more reliably exerted.
[0184] The joining of the upper backing paper 411 and the lower backing paper 412 in the slit portion 42 can be formed by applying pressure, similarly to the first embodiment.
[0185] When the leakproof sheet 3 and the absorbent body 4 are bonded together using an adhesive, the adhesive-coated portion where the adhesive is present when viewed from above is located in at least a portion of the formation range of the slit portion 42, so that the leakproof sheet 3 and the lower lining paper 412 can be joined in the slit portion 42.
[0186] From the viewpoint of deepening the depth in the thickness direction Z of the absorbent body skin side recess 45a which is recessed toward the non-skin side and thereby making a wider area of the deep depth of the front part recess 20 formed by the absorbent body skin side recess 45a, in the slit portion 42 when viewed from above, the proportion of the adhesive coating portion relative to the plane area of the slit portion 42 is preferably 20% or more, and more preferably 40% or more.
[0187] In the slit portion 42, a region where a space S is provided between the leakage preventing sheet 3 and the lower layer backing paper 412 as in the first embodiment and a region where the leakage preventing sheet 3 and the lower layer backing paper 412 are joined but no space S is provided as in the third embodiment may exist in combination.
[0188] The ratio of the area where the space S is provided to the area where the space S is not provided in the slit 42 can be appropriately adjusted by the pattern shape of the adhesive disposed between the leakage preventing sheet 3 and the absorbent body 4 in the slit 42 .
[0189] From the viewpoint of expanding the contact range between the excrement and the metal oxide antimicrobial agent in the recessed portion 20 of the front member, in the slit portion 42, the proportion of the area where the leakproof sheet 3 and the lower backing paper 412 are joined, that is, the area where the space S is not provided, is preferably high.
[0190] The adhesive disposed between the upper backing paper 411 and the absorbent core 40 and the adhesive disposed between the lower backing paper 412 and the absorbent core 40 are applied in an intermittent pattern in which the applied portion and the non-applied portion are alternately arranged in the longitudinal direction X and the transverse direction Y, for example, over the overlapping area of the two when viewed from above. The application pattern is not limited to this.
[0191] Typically, the adhesive is applied in a spiral shape extending along the conveyance direction (corresponding to the longitudinal direction X of the product) of the absorbent body 4 during manufacture, and is arranged at intervals at a plurality of locations in a direction perpendicular to the conveyance direction.
[0192] The adhesive disposed between the leakage preventing sheet 3 and the absorbent body 4 is applied in an intermittent pattern in which applied portions and non-applied portions are alternately arranged in the longitudinal direction X and the lateral direction Y, for example, over the entire overlapping region of the two in plan view.
[0193] Typically, the adhesive is applied in a spiral shape extending along the conveying direction of the absorbent body 4 during manufacture (the longitudinal direction X of the absorbent core when manufactured into a diaper) and arranged at intervals at a plurality of locations in a direction perpendicular to the conveying direction.
[0194] In addition, the coating pattern is not limited to this, and for example, a linear pattern shape extending in the longitudinal direction X may be used in which the coating portions are continuously arranged in the longitudinal direction X so as to overlap with the slit portions 42 in a plan view.
[0195] The front member recess 20 formed on the skin side 2a of the front member 2 and recessed toward the non-skin side substantially along the shape of the absorbent skin side recess 45a can be typically formed by applying an adhesive between the front member 2 and the upper backing paper 411 and pressurizing the absorbent skin side recess 45a joined to the front member 2 in the thickness direction Z using a pressing roller. In addition, the manufacturing method is not limited to the method described herein.
[0196] In addition, in this embodiment, an example is given in which the front member recess 20 is composed of only a multilayer structure, but as in the second embodiment, a part of the front member recess 20 may be a multilayer structure and the other part may be a single-layer structure. Preferably, the front member recess 20 includes a multilayer structure.
[0197] <Fourth Embodiment>
[0198] In the first to third embodiments, an example in which the slit portion 42 is one is given, but a plurality of slit portions 42 may be provided. The diaper 1C of this embodiment is different from the diaper 1 of the first embodiment only in the number of slit portions 42. Here, an example in which the slit portions 42 are two is given and used. Fig.10 Although this is described above, the number of slit portions 42 may be three or more.
[0199] In the present embodiment, by providing two slit portions 42, two absorbent body skin-side recessed portions 45a and two front member recessed portions 20 are formed.
[0200] In addition, Fig.10 In the example shown in (B), an example is given in which an absorbent non-skin side recess 45b is formed on the non-skin side of the absorbent 4, and a space S exists between the lower backing paper 412 and the leakproof sheet 3, but the present invention is not limited thereto. As shown in the third embodiment, the lower backing paper 412 may be joined to the leakproof sheet 3 in the slit 42, and the depth of the front member recess 20 may be deepened as a result. In addition, a configuration may be made in which a region where the lower backing paper 412 and the leakproof sheet 3 are joined and a region where the space S is formed between the lower backing paper 412 and the leakproof sheet 3 exist in a mixed manner.
[0201] In addition, Fig.10 In the example shown in (B), both of the two front member recesses 20 are composed of only a multilayer structure, but the front member recesses 20 may be composed of a part of a multilayer structure and the other part of a single-layer structure as in the second embodiment.
[0202] like Fig.10 As shown in (A) of FIG. 1 , the absorbent body 4C constituting a part of the diaper 1C of the present embodiment has a pair of slits 42 extending in the longitudinal direction X in the crotch region C and arranged symmetrically with respect to the longitudinal center line CL.
[0203] By providing a plurality of slits 42, the diffusion of excrement in the surface direction is further promoted, and the wearing feeling and the fit are improved.
[0204] like Fig.10 As shown in (B), the upper backing paper 411 and the lower backing paper 412 are joined at the slit portion 42, so that two absorbent body skin side recesses 45a recessed toward the non-skin side are formed by the slit portion 42 on the skin side 4Ca of the absorbent body 4C.
[0205] In addition, two absorbent body non-skin side recessed portions 45 b recessed toward the skin side are formed on the non-skin side 4Cb of the absorbent body 4C by the slit portion 42 .
[0206] By positioning the front piece 2 at a position along the shape of the absorber skin side recess 45a and covering the absorber skin side recess 45a, two front piece recesses 20 recessed toward the non-skin side are formed on the skin side 2a of the front piece 2 using the absorber skin side recess 45a.
[0207] The front element recess 20 is formed by a first region 21 .
[0208] By providing a plurality of front member recesses 20 in this manner, the contact range between the metal oxide antimicrobial agent located in the front member recess 20 constituted by the first region 21 where the metal oxide antimicrobial agent is relatively abundant and the excrement in the front member recess 20 can be expanded compared to the case where only one is provided. As a result, the amount of the metal oxide antimicrobial agent dissolved into the liquid excrement in the plurality of front member recesses 20 increases, and a more efficient antimicrobial performance can be exhibited.
[0209] In addition, in the fifth embodiment, the front member recess 20 is formed of a multi-layer structure similar to the first embodiment. By forming a multi-layer structure, liquid excreta can be easily stored in the front member recess 20 for a long time, and the metal oxide antimicrobial agent can be dissolved into the liquid excreta for a longer time, so that the antimicrobial effect can be exerted more reliably.
[0210] As in the above embodiments, in the present invention, the front piece has a front piece recessed portion formed by the slit portion of the absorbent core on the skin side thereof, and a relatively large amount of the metal oxide antimicrobial agent is present in the front piece recessed portion. Thus, a diaper (absorbent article) that can exhibit highly efficient antimicrobial performance can be obtained, and skin rashes caused by an imbalance of resident bacteria in the skin can be suppressed.
[0211] Furthermore, it is more preferable that the recessed portion of the front member is constructed in a manner that includes a multilayer structure, thereby being able to exhibit more efficient antibacterial properties.
[0212] <Supplementary matters>
[0213] [Fiber structure and concave part confirmation method]
[0214] The structure of the fibers contained in the front material can be confirmed by enlarging and observing the cut surface after the front material is cut.
[0215] The front part of the object to be measured is cut with a razor (e.g., single-edged manufactured by Feather Safety Razor Co., Ltd.) to obtain a measuring piece that is a quadrilateral shape (8 mm × 4 mm) when viewed from above. When cutting the object to be measured, care should be taken to ensure that the structure of the cut surface of the measuring piece formed by the cutting is not destroyed by the pressure during cutting. As a preferred method for cutting the object to be measured, a method can be exemplified in which the object to be measured is placed in liquid nitrogen to be fully frozen before cutting the object to be measured and then cut.
[0216] The measuring piece was attached to the sample stage using a paper double-sided tape (NW-15 manufactured by NICHIBAN Co., Ltd.). Next, the measuring piece was subjected to platinum coating. During the coating, an ion sputtering device E-1030 (trade name) manufactured by Hitachi Naka Seiki Co., Ltd. was used, and the sputtering time was set to 30 seconds.
[0217] The cut surface of the measurement piece was observed at a magnification of 1000 times using an S-4000 field emission type operation electron microscope manufactured by Hitachi, Ltd.
[0218] By observing the cut surface of the front material, in addition to the cross-sectional profile of the fiber, the fiber structure such as whether it is a core-sheath type fiber or a single fiber structure can be understood.
[0219] Moreover, in the case of core-sheath type fibers, the area ratio of the core and the sheath can be calculated by observing the cut surface. In addition, by observing the cut surface, the presence of the metal oxide antibacterial agent in the fiber can be confirmed, and the situation where the metal oxide antibacterial agent is only configured in the sheath can be confirmed.
[0220] In addition, the upper layer and the lower layer can be confirmed by the difference in the constituent fibers in the cut surface of the front member. Therefore, the distribution of the metal oxide antimicrobial agent mixed fibers in the upper layer and the lower layer can be confirmed by observing the cut surface of the front member.
[0221] In addition, the diaper is cut along the transverse direction Y so as to pass through the slit portion of the absorbent core, and the presence of the absorbent body skin-side recessed portions and the front material recessed portions can be confirmed from the cut surface image.
[0222] In addition, by performing SEM-EDX analysis on the fiber cross section, it was confirmed that the agent contained in the sheath was zinc oxide (metal oxide antibacterial agent).
[0223] [Calculation method of the ratio of the metal oxide antimicrobial agent contained in the first region or the second region relative to the entire front member]
[0224] Cut the object (first area or second area) of the front part with a razor (e.g., single-edged razor manufactured by Feather Safety Razor Co., Ltd.), cut out a sample of a specified area, and measure its mass. In the method for calculating the mass of the metal oxide antibacterial agent based on the sample described below, the amount of the reagents used in the calculation is relative to the amount of 1g of the sample, and the following reagents are changed to amounts corresponding to the mass of the sample.
[0225] The sample was cut into small pieces as small as possible and placed in a 300 ml beaker. 200 ml of ion exchange water was then added to the beaker and stirred with a magnetic stirrer to allow the fiber to be completely in contact with the water. 3 ml of concentrated hydrochloric acid (about 10 M) was added little by little while stirring the liquid, and further stirred for 1 hour to dissolve the metal oxide antibacterial agent present on the surface of the fiber constituting the second layer. Next, 6 ml of 5.1 M sodium hydroxide aqueous solution was added to neutralize the liquid, and 10 ml of pH 10.7 buffer solution (containing 54.7 ml of 28 mass % NH3 aqueous solution and 0.535 g of NH4Cl, dissolved in ion exchange water) was added to fine-tune the pH.
[0226] Next, add chrome black T reagent (a reagent obtained by dissolving chrome black T powder 0.125g and hydroxylamine hydrochloride 1.125g in anhydrous ethanol 25ml) as an indicator to make the liquid light pink. Use 0.0002M EDTA·2Na as a titrant for titration, and take the amount of the titrant added (ml) when the liquid changes color from pink to light blue to green as the titration value A. Then, calculate the mass of the metal oxide antibacterial agent by the following formula. "5000000" in the following formula refers to the volume (ml) of the titrant per 1 mol.
[0227] The mass of metal oxide antibacterial agent (g) = titration value A × the mass of metal oxide antibacterial agent per 1 mol / 5000000
[0228] The mass of the metal oxide antimicrobial agent calculated in the above manner is the mass of the metal oxide antimicrobial agent contained in the sample. The mass of the metal oxide antimicrobial agent per unit area of the first region (second region) as the calculation object is obtained by dividing the mass of the metal oxide antimicrobial agent by the area of the sample.
[0229] Next, the area of the first region as a whole (the second region as a whole) is calculated, and the mass of the metal oxide antibacterial agent per unit area of the first region (the second region as a whole) obtained from the sample is multiplied by the area of the first region as a whole (the second region as a whole), thereby calculating the mass of the metal oxide antibacterial agent in the first region as a whole (the second region as a whole).
[0230] Next, the mass of the entire front piece is measured, the mass of the metal oxide antibacterial agent in the first area as a whole (the second area as a whole) is divided by the mass of the entire front piece, and then multiplied by 100 to calculate the proportion (mass %) of the metal oxide antibacterial agent contained in the first area (or the second area) relative to the entire front piece.
[0231] [Calculation method of the ratio of metal oxide antimicrobial agent in metal oxide antimicrobial agent mixed fiber]
[0232] When the upper layer 23 is composed only of metal oxide antimicrobial agent mixed fibers, the proportion of the metal oxide antimicrobial agent in the metal oxide antimicrobial agent mixed fibers can be calculated as follows.
[0233] If it is difficult to cut out 1 g of the upper layer, cut out a piece of an arbitrary size, measure its mass, and change the reagents etc. to an amount corresponding to the mass.
[0234] Next, the mass of the metal oxide antimicrobial agent is calculated by the same method as the method for calculating the ratio of the metal oxide antimicrobial agent contained in the first region or the second region to the entire front member.
[0235] The mass of the metal oxide antimicrobial agent calculated in this way is the mixed amount of the metal oxide antimicrobial agent contained in 1g of the upper layer, that is, 1g of the metal oxide antimicrobial agent mixed fiber (mixed amount per unit mass). Therefore, the value of 100 times the mass of the calculated metal oxide antimicrobial agent becomes the proportion of the metal oxide antimicrobial agent in the metal oxide antimicrobial agent mixed fiber.
[0236] [Method for measuring the solubility of metal oxide antimicrobial agents]
[0237] 5 g of the metal oxide antibacterial agent was added to 100 ml of water, and stirred at 300 rpm for 30 minutes at room temperature (25° C.) In addition, the mass of the filter paper was measured, and the measured mass was taken as the initial mass of the filter paper.
[0238] The stirred solution was filtered using the filter paper after the mass measurement, and the filter paper was dried in a dryer at 40° C. for 2 hours. The mass of the dried filter paper was measured, and the measured mass was taken as the mass of the dried filter paper. Then, the solubility was calculated by the following formula.
[0239] Solubility (g) = 5 (g) - {(mass of filter paper after drying) (g) - (initial mass of filter paper) (g)}
[0240] The larger the solubility calculated in this way, the greater the solubility in water, and the smaller the solubility, the lower the solubility in water.
[0241] <Other Implementation Methods>
[0242] As mentioned above, although embodiment of this invention was described, this invention is not limited to the said embodiment, It is a matter of course that various changes can be added within the range which does not deviate from the summary of this invention.
[0243] For example, in the above embodiments, a pants-type disposable diaper is shown as an absorbent article, but the present invention is not limited thereto. The absorbent article of the present invention may also be, for example, an unfolded disposable diaper, a disposable menstrual panties (a menstrual absorbent article), a urine-absorbing pad, a vaginal discharge sheet, a sanitary napkin, etc.
[0244] In addition, for example, in a core-sheath type metal oxide antimicrobial agent mixed fiber, not only the metal oxide antimicrobial agent is mixed in the sheath portion, but also a light scattering substance such as titanium oxide can be mixed in the core portion. Thus, it is possible to form a front surface member in which dirt (high concealment) caused by absorbed liquid excrement (urine, soft stool, blood, etc.) is not easily visible from the skin side surface.
[0245] In each of the above-mentioned embodiments, the metal oxide antimicrobial agent mixed fibers may contain an antimicrobial agent such as a surfactant or an organic compound other than the metal oxide antimicrobial agent.
[0246] In addition, the metal oxide antimicrobial agent mixed fiber may also contain a skin care agent.
[0247] As the skin care agent, a hydrophobic skin care agent, a hydrophilic skin care agent, etc. can be used.
[0248] A hydrophobic skin care agent refers to a hydrophobic component that is not water-soluble and water-dispersible, or has extremely low solubility, and is a composition or compound that has effects such as protecting and healing the skin of the wearer. More specifically, a hydrophobic component refers to a component in which the amount of dissolution when 10 g of the reagent is mixed in 1 L of ion exchange water and then left to stand for 24 hours is less than 1 g, preferably 0.1 g or less, and particularly preferably no dissolution at all.
[0249] As hydrophobic skin care agents, fatty acids with a carbon chain length of 12 to 28 or ester compounds of the fatty acids and glycerol, waxes, vaseline, etc. can be cited, and unsaturated fatty acids with a carbon chain difference length of 12 to 28 or glyceride compounds of the unsaturated fatty acids are particularly preferred. The glyceride is a monoester, diester or triester of glycerol and the above-mentioned unsaturated fatty acids, and triesters are particularly preferred. As agents containing fatty acids or fatty acid compounds, natural extracts such as argan oil and shea butter can be preferably used. In particular, argan oil, which is a hydrophobic vegetable oil containing unsaturated fatty acids, maintains the balance of moisture and oil in the skin and prevents dryness, and functions as a skin care agent. In addition, argan oil contains a large amount of unsaturated fatty acids such as oleic acid and linoleic acid, and has a strong ability to remove active oxygen, for example, it can reduce skin damage caused by sun exposure.
[0250] On the other hand, a hydrophilic skin care agent refers to a water-soluble or water-dispersible hydrophilic component, and is preferably a skin care agent that can inhibit the occurrence of rash or inflammation, and when rash or inflammation occurs, can inhibit the progression of the rash or inflammation, or alleviate the rash or inflammation. More specifically, a hydrophilic component refers to a component that dissolves or disperses in an amount of 1 g or more, preferably 5 g or more, more preferably 1 g or more, further preferably 5 g or more, and most preferably completely dissolved when 10 g of the component is mixed in 1 L of ion exchange water and allowed to stand for 24 hours.
[0251] As the hydrophilic skin care agent, there can be used natural extracts such as peach leaf extract and witch hazel extract, polyols having 2 to 4 carbon chains, polyethylene glycol, and hydrophilic compounds having skin care functions.
[0252] Among them, peach leaf extract (hydrophilic extract) as a plant extract has antibacterial and anti-inflammatory effects, so it is preferred. The peach leaf extract as a hydrophilic component dissolves in the liquid supplied to the positive part and transfers to the skin, thereby producing a skin care effect.
[0253] The polyol with a carbon chain number of 2 to 4 is a hydrophilic component, typically 1,3-butanediol. By using 1,3-butanediol, the moisturizing effect and lubricity are improved. By improving the lubricity, the friction between the skin and the nonwoven fabric can be reduced, and damage to the skin can be suppressed. 1,3-Butanediol is a liquid water-soluble base component with moisturizing properties. It has a dry feel and less stickiness, and keeps the skin moist. In addition to being used as a moisturizer, 1,3-butanediol is also used as a solvent. For example, when peach leaf extract is used as a skin care agent, 1,3-butanediol can be used as a solvent for the peach leaf extract. In addition, here, 1,3-butanediol is used as an example, but as long as it is a polyol with a carbon chain number of 2 to 4, it will show the same effect, for example, propylene glycol can also be used. Propylene glycol can also be used as an extraction solvent for peach leaf extract (hydrophilic extract).
[0254] The present invention can also adopt the following structures.
[0255] <1>
[0256] An absorbent article having a longitudinal direction extending from the wearer's ventral side through the crotch portion to the back side, and a transverse direction orthogonal to the longitudinal direction, and divided into a ventral region, a crotch region, and a back region along the longitudinal direction, the absorbent article having:
[0257] absorbent bodies arranged in the ventral region, the crotch region, and the dorsal region; and
[0258] a front member located on the skin side of the absorbent body,
[0259] The absorbent body has:
[0260] An absorbent core having a skin side and a non-skin side and having a slit portion penetrating in a thickness direction;
[0261] an upper backing paper covering the skin side including the slit portion; and
[0262] a lower backing paper covering the non-skin side including the slit portion,
[0263] The upper backing paper and the lower backing paper are joined at the gap.
[0264] The absorbent body has an absorbent body skin side concave portion formed by the slit portion on the skin side thereof,
[0265] The front member has a front member concave portion formed by the skin-side concave portion of the absorbent body on its skin-side side.
[0266] The front member includes: a first region containing a metal oxide antimicrobial agent; and a second region in which the amount of the metal oxide antimicrobial agent mixed is less than that of the first region,
[0267] The front member recess is formed by the first area,
[0268] The metal oxide antimicrobial agent is contained in the fiber.
[0269] <2>
[0270] The absorbent article as described in <1> above, wherein
[0271] The metal oxide antibacterial agent is mixed with the fiber.
[0272] <3>
[0273] The absorbent article as described in <1> or <2> above, wherein:
[0274] The recessed portion of the front member includes a multi-layer structure.
[0275] <4>
[0276] The absorbent article as described in <3> above, wherein:
[0277] The front member includes: an upper layer containing the metal oxide antimicrobial agent; and a lower layer in which the mixing amount of the metal oxide antimicrobial agent is less than that of the upper layer.
[0278] The first region includes the upper layer,
[0279] The second region includes the lower layer and does not include the upper layer,
[0280] The multi-layer structure portion of the recessed portion of the front member is composed of the upper layer and the lower layer.
[0281] <5>
[0282] The absorbent article as described in <4> above, wherein:
[0283] The first region includes an overlapping region where the upper layer and the lower layer overlap in a plan view.
[0284] <6>
[0285] The absorbent article as described in <4> or <5> above, wherein:
[0286] The first region includes a non-overlapping region including the upper layer and excluding the lower layer.
[0287] <7>
[0288] The absorbent article according to any one of <4> to <6>, wherein:
[0289] The ratio of the metal oxide antimicrobial agent mixed fiber as the fiber containing the metal oxide antimicrobial agent in the entire upper layer is 30 mass % or more, more preferably 80 mass % or more, and further preferably 100 mass %.
[0290] The ratio of the metal oxide antimicrobial agent mixed fiber to the entire lower layer is preferably 50% by mass or less, more preferably 30% by mass or less, and even more preferably 0% by mass.
[0291] <8>
[0292] The absorbent article according to any one of <1> to <7>, wherein:
[0293] The first region overlaps the transverse central region in the crotch region when viewed from above,
[0294] The second region is located laterally outward of the first region in the crotch region.
[0295] <9>
[0296] The absorbent article according to any one of <1> to <8>, wherein:
[0297] The proportion of the fibers containing the metal oxide antimicrobial agent in the first region, i.e., the metal oxide antimicrobial agent mixed fibers, in the metal oxide antimicrobial agent mixed fibers of the entire front member is preferably 30% by mass or more, more preferably 50% by mass or more.
[0298] The proportion of the metal oxide antimicrobial mixed fibers in the second region in the entire metal oxide antimicrobial mixed fibers of the front member is preferably less than 30% by mass, more preferably 10% by mass or less, and even more preferably 0% by mass.
[0299] <10>
[0300] The absorbent article according to any one of <1> to <9>, wherein:
[0301] The ratio of the metal oxide antimicrobial agent contained in the first region to the entire front member is preferably 0.001 mass % or more, more preferably 0.004 mass % or more.
[0302] The ratio of the metal oxide antimicrobial agent contained in the second region to the entire front member is preferably less than 2.0% by mass, more preferably 0.5% by mass or less, and further preferably 0% by mass.
[0303] <11>
[0304] The absorbent article according to any one of <1> to <10>, wherein:
[0305] The fiber containing the metal oxide antimicrobial agent in the first region, i.e., the metal oxide antimicrobial agent mixed fiber, is a core-sheath type fiber having a core and a sheath.
[0306] The metal oxide antimicrobial agent is mixed only in the sheath portion, and the metal oxide antimicrobial agent is exposed on the surface of the metal oxide antimicrobial agent mixed fiber.
[0307] <12>
[0308] The absorbent article as described in <11> above, wherein:
[0309] The ratio of the metal oxide antimicrobial agent in the core-sheath fiber is preferably 0.05% by mass or more and 2.5% by mass or less, and more preferably 0.1% by mass or more and 2.0% by mass or less.
[0310] <13>
[0311] The absorbent article as described in <11> or <12> above, wherein:
[0312] In the core-sheath fiber, the ratio of the metal oxide antimicrobial agent in the resin constituting the sheath portion is preferably 0.1 mass % or more and 5.0 mass % or less, and more preferably 0.2 mass % or more and 4.0 mass % or less.
[0313] <14>
[0314] The absorbent article according to any one of <1> to <13>, wherein:
[0315] The solubility of the metal oxide antibacterial agent in water is preferably 0.01 g / 100 ml to 0.5 g / 100 ml, more preferably 0.03 g / 100 ml to 0.3 g / 100 ml, and further preferably 0.05 g / 100 ml to 0.2 g / 100 ml.
[0316] <15>
[0317] The absorbent article according to any one of <1> to <14> above, wherein:
[0318] The absorbent core has a plurality of the slits.
[0319] <16>
[0320] The absorbent article according to any one of <1> to <15>, wherein:
[0321] It also has a back member located on the non-skin side of the absorbent body,
[0322] A space is formed between the lower backing paper and the backing member at a position corresponding to the slit portion.
[0323] <17>
[0324] The absorbent article according to any one of <1> to <15>, wherein:
[0325] It also includes a back member located on the non-skin side of the absorbent body,
[0326] The lower backing paper and the backing member are joined at a position corresponding to the slit portion.
[0327] Possibility of Industrial Application
[0328] According to the absorbent article of the present invention, it is possible to exhibit highly efficient antibacterial performance.
Claims
1. An absorbent article having a longitudinal direction extending from the wearer's ventral side through the crotch portion to the back side, and a transverse direction orthogonal to the longitudinal direction, and divided into a ventral region, a crotch region and a back region along the longitudinal direction, the absorbent article being characterized in that: absorbent bodies arranged in the ventral region, the crotch region, and the dorsal region; and a front member located on the skin side of the absorbent body, The absorbent body has: An absorbent core having a skin side and a non-skin side and having a slit portion penetrating in a thickness direction; An upper backing paper covering the skin side including the slit portion; and a lower backing paper covering the non-skin side including the slit portion, The upper backing paper and the lower backing paper are joined at the gap. The absorbent body has an absorbent body skin side concave portion formed by the slit portion on the skin side thereof, The front member has a front member concave portion formed by the skin-side concave portion of the absorbent body on its skin-side side. The front part comprises: a first region comprising a metal oxide antimicrobial agent; and a second region in which the amount of the metal oxide antimicrobial agent mixed is less than that of the first region, The front member recess is formed by the first area, The metal oxide antimicrobial agent is contained in the fiber.
2. The absorbent article according to claim 1, characterized in that: The metal oxide antibacterial agent is mixed with the fiber.
3. The absorbent article according to claim 1 or 2, characterized in that: The recessed portion of the front member includes a multi-layer structure.
4. The absorbent article according to claim 3, characterized in that: The front member includes: an upper layer containing the metal oxide antimicrobial agent; and a lower layer in which the mixing amount of the metal oxide antimicrobial agent is less than that of the upper layer. The first region includes the upper layer, The second region includes the lower layer and does not include the upper layer, The multi-layer structure portion of the recessed portion of the front member is composed of the upper layer and the lower layer.
5. The absorbent article according to claim 4, characterized in that: The first region includes an overlapping region where the upper layer and the lower layer overlap in a plan view.
6. The absorbent article according to claim 4 or 5, characterized in that: The first region includes a non-overlapping region including the upper layer and excluding the lower layer.
7. The absorbent article according to any one of claims 4 to 6, characterized in that: The metal oxide antimicrobial agent mixed fiber, which is the fiber containing the metal oxide antimicrobial agent, accounts for 30% by mass or more of the entire upper layer. The ratio of the metal oxide antimicrobial agent mixed fiber to the entire lower layer is 50 mass % or less.
8. The absorbent article according to any one of claims 1 to 7, characterized in that: The first region overlaps the transverse central region in the crotch region when viewed from above, The second region is located laterally outward of the first region in the crotch region.
9. The absorbent article according to any one of claims 1 to 8, characterized in that: The ratio of the fibers containing the metal oxide antimicrobial agent in the first region, i.e., the metal oxide antimicrobial agent mixed fibers, to the metal oxide antimicrobial agent mixed fibers in the entire front member is 30% by mass or more. The ratio of the metal oxide antimicrobial agent mixed fibers in the second region to the metal oxide antimicrobial agent mixed fibers in the entire front member is less than 30 mass %.
10. The absorbent article according to any one of claims 1 to 9, characterized in that: The ratio of the metal oxide antimicrobial agent contained in the first region to the entire front member is 0.001 mass % or more, The ratio of the metal oxide antimicrobial agent contained in the second region to the entire front member is less than 2.0 mass %.
11. The absorbent article according to any one of claims 1 to 10, characterized in that: The fiber containing the metal oxide antimicrobial agent in the first region, i.e., the metal oxide antimicrobial agent mixed fiber, is a core-sheath type fiber having a core and a sheath. The metal oxide antimicrobial agent is mixed only in the sheath portion, and the metal oxide antimicrobial agent is exposed on the surface of the metal oxide antimicrobial agent mixed fiber.
12. The absorbent article according to claim 11, characterized in that: The ratio of the metal oxide antimicrobial agent in the core-sheath type fiber is 0.05 mass % or more and 2.5 mass % or less.
13. The absorbent article according to claim 11 or 12, characterized in that: In the core-sheath type fiber, the ratio of the metal oxide antimicrobial agent to the resin constituting the sheath portion is 0.1 mass % or more and 5.0 mass % or less.
14. The absorbent article according to any one of claims 1 to 13, characterized in that: The solubility of the metal oxide antibacterial agent in water is greater than or equal to 0.01 g / 100 ml and less than or equal to 0.5 g / 100 ml.
15. The absorbent article according to any one of claims 1 to 14, characterized in that: The absorbent core has a plurality of the slits.
16. The absorbent article according to any one of claims 1 to 15, characterized in that: It also has a back member located on the non-skin side of the absorbent body, A space is formed between the lower backing paper and the backing member at a position corresponding to the slit portion.
17. The absorbent article according to any one of claims 1 to 15, characterized in that: It also includes a back member located on the non-skin side of the absorbent body, The lower backing paper and the backing member are joined at a position corresponding to the slit portion.
